General Manager Yu Jianhong went to Yunnan and Guizhou enterprises to guide the work.
Release time:
2022-01-04
News from our newspaper 12# February 22 and 24 , Yu Jianhong, general manager of the group company, went to Yunnan Jianfeng and Guizhou Huangping Jianfeng to inspect and guide the work.
In Yunnan Peak, Yu Jianhong went deep into the production site and had a comprehensive and detailed understanding of the recent production and equipment operation, on-site operation management, the effectiveness of technical transformation projects, process and technical indicators and the overall operation of the mine. At the middle-level cadre meeting held on the afternoon of 22 , Yu Jianhong proposed to pay attention to safety education, implement safety education and training, effectively promote safety management and reduce safety risks in view of the current situation of Yunnan peak management. To comprehensively carry out clean factories and improve the quality of employees, strengthen the civilized renovation of the work site, improve the level of equipment management, process management level; To increase the intensity of technical reform, achieve comprehensive optimization of indicators, reduce costs, comprehensively improve the level of automation and information management, achieve efficient management, and enhance the competitiveness of the industry; further promote the construction of green mines, and strive to create the first green mine model in Yunnan; managers and business backbones at all levels should Strengthen self-learning, combine theory with work practice, continuously improve management ability and technical level, and continuously improve the ability to discover, analyze and solve problems, effectively enhance the quality of business, to achieve the common development of individuals and enterprises.
24At the peak of Huangping, Guizhou, Yu Jianhong held a management meeting to exchange views after carefully checking and understanding the operation of the equipment at the production site. 2021 is the first complete year since Huang Ping's peak was put into production. Under the influence of unfavorable factors such as drastic market fluctuations, power restriction and production restriction, and large price fluctuations of raw fuel materials, he still completed the established business objectives and was fully affirmed by Yu Jianhong. In view of the current production and operation situation of Huang Ping Jianfeng, Yu Jianhong asked the management team to further improve and perfect from the following aspects: economic and technical indicators continue to be fully optimized to reduce production costs; Do a good job in site renovation and create a clean factory according to the standards of 5S ; Do a good job in fine and standardized management; Do a good job in safety management and discover potential safety hazards of on-site equipment in time; Do a good technical renovation projects, explore new technology and participate in hazardous waste disposal projects as soon as soon as possible; improve the management level, business ability and comprehensive quality. Yu Jianhong also hopes that managers at all levels will strengthen self-learning, effectively improve their management capabilities, work together, and fulfill their duties to build Huang Ping Peak into a benchmark cement enterprise in Guizhou. (Wang Yingliang Pan Yi)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31